Form4insider filings, from the source

SEC Form 4 · accession 0001203311-18-000026

SEATTLE GENETICS INC /WA · SGEN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Darren S Cline
Officer — EVP, Commercial
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 9, 2018M7,000$16.41A78,831D
Common StockF1May 9, 2018M2,000$15.46A80,831D
Common StockF2,F1May 9, 2018S9,000$55.3314D71,831D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F3$15.46May 9, 2018M2,000D—Aug 24, 2021Common Stock2,000268D
Non-Qualified Stock Option (right to buy)F4$16.41May 9, 2018M7,000D—Oct 29, 2020Common Stock7,000892D

Explanation of responses